Literature DB >> 8061545

Sinus arrest after nimodipine treatment for a head injury.

S D Nash1, M V Patt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061545      PMCID: PMC325156     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


× No keyword cloud information.
  6 in total

1.  Comparative effects of a new calcium channel antagonist, mepirodipine, on rabbit spontaneously beating sino-atrial node cells.

Authors:  H Satoh; K Hashimoto
Journal:  Eur J Pharmacol       Date:  1991-01-25       Impact factor: 4.432

2.  Cerebral arterial spasm: part 9. In vitro effects of nifedipine on serotonin-, phenylephrine-, and potassium-induced contractions of canine basilar and femoral arteries.

Authors:  G S Allen; S B Banghart
Journal:  Neurosurgery       Date:  1979-01       Impact factor: 4.654

3.  Treatment of cerebral vasospasm following severe head injury with the calcium influx blocker nimodipine.

Authors:  H Kostron; E Rumpl; G Stampfl; L Russegger; V Grunert
Journal:  Neurochirurgia (Stuttg)       Date:  1985-05

4.  Prevention of vasospasm in subarachnoid haemorrhage. A controlled study with nimodipine.

Authors:  J Philippon; R Grob; F Dagreou; M Guggiari; M Rivierez; P Viars
Journal:  Acta Neurochir (Wien)       Date:  1986       Impact factor: 2.216

5.  Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial.

Authors:  K C Petruk; M West; G Mohr; B K Weir; B G Benoit; F Gentili; L B Disney; M I Khan; M Grace; R O Holness
Journal:  J Neurosurg       Date:  1988-04       Impact factor: 5.115

6.  Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

Authors:  G S Allen; H S Ahn; T J Preziosi; R Battye; S C Boone; S C Boone; S N Chou; D L Kelly; B K Weir; R A Crabbe; P J Lavik; S B Rosenbloom; F C Dorsey; C R Ingram; D E Mellits; L A Bertsch; D P Boisvert; M B Hundley; R K Johnson; J A Strom; C R Transou
Journal:  N Engl J Med       Date:  1983-03-17       Impact factor: 91.245

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.